A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects
Clinical trial NCT05549531 · COMPLETED
Trial details
- NCT number
- NCT05549531
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2022-10-20
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.